Payer-Provider Debates on Applications of New HIV Treatment Breakthroughs is organized by Prime Education, LLC.
Release Date: August 30, 2019
Expiration Date: August 29, 2020
Accreditation:
• 1.0 CE for Physicians (AMA Category 1)
• 1.0 CE for Physician Assistants
• 1.0 CE for Nurse Practitioners
• 1.0 CE for Pharmacists (Automatic NABP)
• 1.0 CE for Nurses
• 1.0 CE for Case Managers (CCMC)
• 1.0 CE for Health Education Specialists
Learning Objectives:
• Differentiate new and emerging antiretroviral therapies (ART) based on the latest evidence for their efficacy, safety, and adherence potential
• Apply current guidelines and evidence to decisions on initiating ART or switching ART in the setting of virologic suppression or failure
• Evaluate patient-specific factors, including age, comorbidities, concomitant medications, and adherence challenges, in making decisions about HIV therapy selection
Additional details will be posted as soon as information is available.
Copyrights © 2026 eMedEvents Corporation, All Rights Reserved